Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Greater Cannabis Company Inc GCAN

The Greater Cannabis Company, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of cannabinoid therapeutics. The Company conducts medical research, and is pursuing clinical trials, to develop cannabis-based treatments for various medical conditions and their symptoms with an initial focus on neuropsychiatric disorders. The Company conducts... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:GCAN)

GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy

GlobeNewswire February 27, 2024

GCANRx Featured in American Journal of Endocannabinoid Medicine

GlobeNewswire September 21, 2023

GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders

GlobeNewswire July 5, 2023

GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders

GlobeNewswire October 7, 2022

GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special

GlobeNewswire December 16, 2021

GCANRx Appoints Renowned Cannabinoid Researcher Dr. Adi Aran as Strategic Advisor

GlobeNewswire December 2, 2021

GCANRx Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy

GlobeNewswire November 8, 2021

GCANRx Signs Licensing Agreement with Shaare Zedek Scientific for Innovative Neuropsychiatric Cannabinoid Therapy

GlobeNewswire August 19, 2021

GCANRx Announces Collaboration with Renowned Cannabis Research Lab

GlobeNewswire March 16, 2021
View More News ››

Opinion & Analysis (OTCPK:GCAN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:GCAN)

Tomorrow is the day of Cannabis

US inaguration on Jan 20th.           ...
MoneyStock - January 19, 2021

Will GCAN survive?

Anybody out there?
John2112 - March 18, 2020

Revenue

Does anyone know the 2018 rev for GammaCan Intl?
Rogerthat2 - June 20, 2019

anyone out there?

super low price right now,it could run up to a buck in short order.
sherritt2017 - September 30, 2018
View more Bullboard ››

Majestic Gold Corp.

Majestic Gold Corp.

Majestic Gold Corp. is engaged in mineral resource exploration, development and extraction. It operates the Songjiagou open ...
View More »